JBIO
Jade Biosciences, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:31:10 PM EST
15.17USD-2.066%(-0.32)288,089
JBIO Financials
In Q3 FY 2026 (ended ), Jade Biosciences, Inc. Common Stock (JBIO) reported net income of −$35.06M, operating cash flow of −$28.91M, and assets of $486.39M (filed ).
Loading financial statements…